QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
1-Year Return
19.13%
This Quarter Return
-13.89%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$744M
AUM Growth
-$81.5M
(-9.9%)
Cap. Flow
+$41.6M
Cap. Flow
% of AUM
5.59%
Top 10 Holdings %
Top 10 Hldgs %
31.55%
Holding
2,874
New
241
Increased
1,415
Reduced
721
Closed
183
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.79M |
| 2 |
FIGS
FIGS
|
+$5.02M |
| 3 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$3.58M |
| 4 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$3.4M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$2.19M |
Top Sells
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$4M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$3.23M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.1M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$1.06M |
| 5 |
RMI
RiverNorth Opportunistic Municipal Income Fund
RMI
|
+$900K |
Sector Composition
| 1 | Technology | 12.36% |
| 2 | Healthcare | 7.65% |
| 3 | Financials | 6.69% |
| 4 | Consumer Staples | 6.68% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Warrior Met Coal
HCC
$3.08B
| $10K | ﹤0.01% |
329
+271
| +467% | +$8.24K |
|
1652
Hexcel
HXL
$4.93B
| $10K | ﹤0.01% |
199
+22
| +12% | +$1.11K |
|
1653
Integra LifeSciences
IART
$1.21B
| $10K | ﹤0.01% |
186
+7
| +4% | +$376 |
|
1654
iShares Biotechnology ETF
IBB
$5.77B
| $10K | ﹤0.01% |
85
| – | – |
|
1655
Independent Bank Corp
IBCP
$661M
| $10K | ﹤0.01% |
521
-837
| -62% | -$16.1K |
|
1656
Ionis Pharmaceuticals
IONS
$10.2B
| $10K | ﹤0.01% |
263
-4
| -1% | -$152 |
|
1657
Interparfums
IPAR
$3.47B
| $10K | ﹤0.01% |
143
+109
| +321% | +$7.62K |
|
1658
Johnson Outdoors
JOUT
$416M
| $10K | ﹤0.01% |
166
+115
| +225% | +$6.93K |
|
1659
LCI Industries
LCII
$2.47B
| $10K | ﹤0.01% |
91
+20
| +28% | +$2.2K |
|
1660
Macerich
MAC
$4.61B
| $10K | ﹤0.01% |
1,106
+291
| +36% | +$2.63K |
|
1661
Midland States Bancorp
MSBI
$385M
| $10K | ﹤0.01% |
427
-1,013
| -70% | -$23.7K |
|
1662
NeoGenomics
NEO
$966M
| $10K | ﹤0.01% |
1,213
-474
| -28% | -$3.91K |
|
1663
Odyssey Marine Exploration
OMEX
$75M
| $10K | ﹤0.01% |
2,970
| – | – |
|
1664
PotlatchDeltic
PCH
$3.21B
| $10K | ﹤0.01% |
225
-26
| -10% | -$1.16K |
|
1665
Procore
PCOR
$10.3B
| $10K | ﹤0.01% |
216
+56
| +35% | +$2.59K |
|
1666
PENN Entertainment
PENN
$2.93B
| $10K | ﹤0.01% |
335
+59
| +21% | +$1.76K |
|
1667
Pinnacle Financial Partners
PNFP
$7.59B
| $10K | ﹤0.01% |
133
+33
| +33% | +$2.48K |
|
1668
Primerica
PRI
$8.74B
| $10K | ﹤0.01% |
83
+8
| +11% | +$964 |
|
1669
Prospect Capital
PSEC
$1.29B
| $10K | ﹤0.01% |
+1,391
| New | +$10K |
|
1670
QuidelOrtho
QDEL
$2.03B
| $10K | ﹤0.01% |
107
-69
| -39% | -$6.45K |
|
1671
Qualys
QLYS
$4.75B
| $10K | ﹤0.01% |
80
+24
| +43% | +$3K |
|
1672
Ultragenyx Pharmaceutical
RARE
$3.02B
| $10K | ﹤0.01% |
171
+149
| +677% | +$8.71K |
|
1673
Roblox
RBLX
$92.2B
| $10K | ﹤0.01% |
+297
| New | +$10K |
|
1674
RLI Corp
RLI
$6.08B
| $10K | ﹤0.01% |
174
+150
| +625% | +$8.62K |
|
|
RWT
1675
Redwood Trust
RWT
$802M
| $10K | ﹤0.01% |
1,278
+113
| +10% | +$884 |
|